Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street gains as healthcare stocks rally, oil prices fall
- Brent slips in choppy session as investors weigh attacks on ships, Saudi energy
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
| (NASDAQ: KNSA) | Delayed: 82.06 +2.58 (3.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.48 | 52 Week High | $ | |||
| Open | $80.25 | 52 Week Low | $ | |||
| Day High | $82.09 | P/E | N/A | |||
| Day Low | $79.88 | EPS | $ | |||
| Volume | 215,446 | |||||
